6M
COLL icon

6 Meridian’s Collegium Pharmaceutical COLL Stock Holding History

6 Meridian’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$204K Buy
10,925
+86
+0.8% +$1.68K 0.01% 388
2021
Q3 		$214K Buy
+10,839
New +$234K 0.02% 301

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

6 Meridian's COLL Position: Q4 2021 in Review

6 Meridian increased its Collegium Pharmaceutical (COLL) stake by 0.79% in Q4 2021, buying an estimated $1.68K and bringing the position to 10,925 shares worth $204K. The position accounts for 0.01% of the portfolio, ranked #388.

6 Meridian first reported a position in COLL in Q3 2021 and has held it in 2 quarters since. The position peaked at $214K in Q3 2021. 159 funds tracked by Wall St. Rank hold COLL as of Q4 2021.

  • 6 Meridian held 10,925 shares of Collegium Pharmaceutical worth $204K as of Q4 2021.
  • 6 Meridian bought 86 Collegium Pharmaceutical shares in Q4 2021, an estimated $1.68K.
  • Collegium Pharmaceutical made up 0.01% of 6 Meridian's portfolio in Q4 2021, its #388 holding.
  • 6 Meridian first reported a position in Collegium Pharmaceutical in Q3 2021 and has held it in 2 quarters since.
  • 6 Meridian's Collegium Pharmaceutical position peaked at $214K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.